CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid‑In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		123,170,172
Beginning balance at Dec. 31, 2022	$ 701,338	$ 123	$ 1,049,875	$ (39,951)	$ (308,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		408,025
Exercise of stock options	2,965	$ 1	2,964
Vesting of restricted stock units (in shares)		1,107,382
Vesting of restricted stock units	1	$ 1
Issuance of common stock under the employee stock purchase plan (in shares)		204,962
Issuance of common stock under the employee stock purchase plan	3,131		3,131
Stock-based compensation	49,733		49,733
Foreign currency translation adjustments	11,594			11,594
Net loss	(60,399)				(60,399)
Ending balance (in shares) at Jun. 30, 2023		124,890,541
Ending balance at Jun. 30, 2023	708,363	$ 125	1,105,703	(28,357)	(369,108)
Beginning balance (in shares) at Mar. 31, 2023		123,907,489
Beginning balance at Mar. 31, 2023	705,459	$ 124	1,072,148	(33,904)	(332,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)		40,854
Exercise of stock options	242	$ 1	241
Vesting of restricted stock units (in shares)		737,236
Issuance of common stock under the employee stock purchase plan (in shares)		204,962
Issuance of common stock under the employee stock purchase plan	3,131		3,131
Stock-based compensation	30,183		30,183
Foreign currency translation adjustments	5,547			5,547
Net loss	(36,199)				(36,199)
Ending balance (in shares) at Jun. 30, 2023		124,890,541
Ending balance at Jun. 30, 2023	708,363	$ 125	1,105,703	(28,357)	(369,108)
Beginning balance (in shares) at Dec. 31, 2023		126,938,102
Beginning balance at Dec. 31, 2023	717,547	$ 126	1,162,993	(26,777)	(418,795)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase and retirement of common stock (in shares)		(2,000,000)
Repurchase and retirement of common stock	(35,357)	$ (2)			(35,355)
Exercise of stock options (in shares)		303,638
Exercise of stock options	1,756		1,756
Vesting of restricted stock units (in shares)		2,015,812
Issuance of common stock under the employee stock purchase plan (in shares)		209,047
Issuance of common stock under the employee stock purchase plan	2,729		2,729
Stock-based compensation	46,862		46,862
Foreign currency translation adjustments	(1,501)			(1,501)
Net loss	(39,786)				(39,786)
Ending balance (in shares) at Jun. 30, 2024		127,466,599
Ending balance at Jun. 30, 2024	692,250	$ 124	1,214,340	(28,278)	(493,936)
Beginning balance (in shares) at Mar. 31, 2024		128,333,366
Beginning balance at Mar. 31, 2024	716,070	$ 126	1,183,852	(28,589)	(439,319)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase and retirement of common stock (in shares)		(2,000,000)
Repurchase and retirement of common stock	(35,357)	$ (2)			(35,355)
Exercise of stock options (in shares)		256,055
Exercise of stock options	1,476		1,476
Vesting of restricted stock units (in shares)		668,131
Issuance of common stock under the employee stock purchase plan (in shares)		209,047
Issuance of common stock under the employee stock purchase plan	2,729		2,729
Stock-based compensation	26,283		26,283
Foreign currency translation adjustments	311			311
Net loss	(19,262)				(19,262)
Ending balance (in shares) at Jun. 30, 2024		127,466,599
Ending balance at Jun. 30, 2024	$ 692,250	$ 124	$ 1,214,340	$ (28,278)	$ (493,936)